Nuvo Pharmaceuticals (OTCMKTS:NRIFF) posted its quarterly earnings results on Wednesday. The company reported ($0.54) earnings per share (EPS) for the quarter, Morningstar.com reports. The firm had revenue of $12.40 million during the quarter. Nuvo Pharmaceuticals had a negative net margin of 44.15% and a negative return on equity of 21.93%.
Nuvo Pharmaceuticals stock opened at $0.51 on Friday. The business’s 50-day simple moving average is $0.54 and its 200 day simple moving average is $1.21. Nuvo Pharmaceuticals has a 12-month low of $0.45 and a 12-month high of $2.48. The company has a current ratio of 2.60, a quick ratio of 1.91 and a debt-to-equity ratio of 9.22.
About Nuvo Pharmaceuticals
Receive News & Ratings for Nuvo Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuvo Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.